XTL Biopharmaceuticals Ltd ADR Working Capital to Net Assets Ratio
XTL Biopharmaceuticals Ltd ADR working capital to net assets ratio. XTL Biopharmaceuticals Ltd ADR (XTLB) has a Working Capital to Net Assets ratio of 100.0% as of March 2026. Working capital of $-254.00K (current assets of $166.00K minus current liabilities of $420.00K) is measured against net assets of $-254.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. Check XTL Biopharmaceuticals Ltd ADR (XTLB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of XTL Biopharmaceuticals Ltd ADR (2003–2025)
Working capital to net assets ratio of XTL Biopharmaceuticals Ltd ADR from 2003 to 2025. This chart shows how XTL Biopharmaceuticals Ltd ADR's Working Capital to Net Assets ratio has evolved across 23 annual periods from 2003 to 2025. As of March 2026, the ratio stands at 100.0%, reflecting working capital of $-254.00K against net assets of $-254.00K USD. See XTLB defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
XTL Biopharmaceuticals Ltd ADR Working Capital to Net Assets Ratio by Year (2003–2025)
XTL Biopharmaceuticals Ltd ADR working capital to net assets ratio by year from 2003 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for XTL Biopharmaceuticals Ltd ADR from 2003 to 2025, covering 23 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see XTL Biopharmaceuticals Ltd ADR total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.0% | $-254.00K | $-254.00K | $166.00K | $420.00K | ▲ +116.0 pp |
| 2024 | -16.0% | $-867.00K | $5.43 Million | $1.34 Million | $2.21 Million | ▼ -98.8 pp |
| 2023 | 82.9% | $1.84 Million | $2.22 Million | $2.05 Million | $206.00K | ▼ -7.6 pp |
| 2022 | 90.5% | $3.62 Million | $4.00 Million | $3.81 Million | $187.00K | ▼ -22.1 pp |
| 2021 | 112.6% | $6.01 Million | $5.33 Million | $6.24 Million | $231.00K | ▲ +18.7 pp |
| 2020 | 93.9% | $5.87 Million | $6.25 Million | $6.12 Million | $254.00K | ▼ -0.6 pp |
| 2019 | 94.5% | $6.60 Million | $6.98 Million | $6.83 Million | $232.00K | ▼ -0.9 pp |
| 2018 | 95.4% | $7.94 Million | $8.32 Million | $8.20 Million | $253.00K | ▼ -67.8 pp |
| 2017 | 163.2% | $5.91 Million | $3.62 Million | $6.21 Million | $300.00K | ▲ +73.0 pp |
| 2016 | 90.2% | $2.42 Million | $2.69 Million | $2.75 Million | $330.00K | ▲ +11.9 pp |
| 2015 | 78.4% | $3.83 Million | $4.89 Million | $4.26 Million | $436.00K | ▲ +32.3 pp |
| 2014 | 46.1% | $2.16 Million | $4.68 Million | $3.12 Million | $965.00K | ▼ -10.9 pp |
| 2013 | 57.0% | $3.87 Million | $6.79 Million | $5.09 Million | $1.22 Million | ▲ +34.3 pp |
| 2012 | 22.7% | $2.14 Million | $9.42 Million | $3.79 Million | $1.65 Million | ▼ -5.0 pp |
| 2011 | 27.7% | $955.00K | $3.44 Million | $1.58 Million | $629.00K | ▲ +18.6 pp |
| 2010 | 9.1% | $259.00K | $2.83 Million | $1.22 Million | $963.00K | ▲ +2166.3 pp |
| 2009 | -2157.1% | $-151.00K | $7.00K | $557.00K | $708.00K | ▼ -2254.3 pp |
| 2008 | 97.1% | $1.39 Million | $1.43 Million | $3.39 Million | $2.00 Million | ▼ -2.5 pp |
| 2007 | 99.6% | $8.53 Million | $8.56 Million | $13.90 Million | $5.37 Million | ▼ -0.1 pp |
| 2006 | 99.7% | $22.69 Million | $22.76 Million | $26.10 Million | $3.40 Million | ▼ -1.5 pp |
| 2005 | 101.2% | $11.38 Million | $11.25 Million | $13.79 Million | $2.41 Million | ▼ -2.1 pp |
| 2004 | 103.3% | $20.24 Million | $19.60 Million | $23.77 Million | $3.53 Million | ▲ +6.4 pp |
| 2003 | 96.9% | $19.97 Million | $20.61 Million | $22.97 Million | $3.00 Million | — |